Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether olmesartan medoxomil is effective in the
treatment of coronary atherosclerosis progression and epicardial adipose tissue(EAT) volume
reduction in patients with coronary atherosclerosis detected by coronary CT
angiography(CCTA).